EXPLORE MORE CATEGORIES
- Home
- »
- Our Products
- »
- Ledipasvir Sofosbuvir
Ledipasvir Sofosbuvir
Prominent & Leading Exporter from Nagpur, we offer ledipasvir tablets, ledifos tablet, ledifos sofosbuvir, ledipasvir sofosbuvir medicines and ledifos.
Ledipasvir Tablets
Get Latest Price
Product Details:
| Dosage Form | Tablet |
| Brand | Hetero |
| Dose/Strength | Ledipasvir 90 mg and Sofosbuvir 400 mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Form | Tablets |
Other details:
- Ledifos is indicated for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection.
- Ledifos is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration.
Description:
- Brand Name: Ledifos Tablets
- Contents : Ledipasvir and Sofosbuvir
- Manufactured by : Hetero Healthcare Limited
- Form: Tablets
- Strength: Ledipasvir 90 mg and Sofosbuvir 400 mg
- Packing: Pack of 28 tablets
Get Best QuoteRequest A Callback
Ledifos tablet
Get Latest Price
Product Details:
| Dosage Form | Tablet |
| Brand | Care |
| Form | Tablet |
| Grade | Medicinal |
| Product Type | API |
| Pack Strip | Strip |
Ledifos is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase.
Recommended Dosage
The recommended dosage of Ledifos is one tablet taken orally once daily with or without food [seeClinical Pharmacology (12.3)].
Duration of Treatment
Relapse rates are affected by baseline host and viral factors and differ between treatment durations for certain subgroups [see Clinical Studies (14)].
Table 1 shows the recommended Ledifos treatment duration based on patient population.
For patients with HCV/HIV-1 co-infection, follow the dosage recommendations in Table 1 [see Clinical Studies (14)]. Refer to Drug Interactions (7) for dosage recommendations for concomitant HIV-1 antiviral drugs.
Additional Information:
- Port of Dispatch: Mumbai
- Production Capacity: 500
- Delivery Time: 5 to 7 days
- Packaging Details: 28 tablets per bottle
Get Best QuoteRequest A Callback
Ledifos Sofosbuvir
Get Latest Price
Product Details:
| Dosage Form | Tablet |
| Drug Name | LEDIFOS SOFOSBUVIR |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Form | Tablet |
| Product Type | API |
Ledifos Tablets. This is processed using quality approved chemical compounds with latest techniques to ensure maximum effectiveness. It is highly demanded in medical industry and is widely used in the treatment of (HCV) Infection. Our offered medicine is freely soluble in liquid. Furthermore, the offered can be availed in diverse packaging options at economical prices.
Other Information
- Minimum Order Quantity: 1 Piece
- Port of Dispatch: mumbai
- Delivery Time: 7 day
- Packaging Details: one unit contain 28 tablets
Get Best QuoteRequest A Callback
Ledipasvir Sofosbuvir Medicines
Get Latest Price
Ledipasvir is a prescription drug and should be used under proper medical guidance and advice.The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Ledipasvir Sofosbuvir
Hepcinat LP Tablets
Ledifos Tablets
Hepcvir L Tablets
Resof L Tablets
Lisof Tablets
Ledviclear Tablets
Myhep Lvir Tablets
Ledipasvir Sofosbuvir
Hepcinat LP Tablets
Ledifos Tablets
Hepcvir L Tablets
Resof L Tablets
Lisof Tablets
Ledviclear Tablets
Myhep Lvir Tablets
Get Best QuoteRequest A Callback
Ledifos
Get Latest Price
Product Details:
| Dosage Form | Tablet |
Ledifos is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase.
Recommended Dosage
The recommended dosage of Ledifos is one tablet taken orally once daily with or without food [seeClinical Pharmacology (12.3)].
Duration of Treatment
Relapse rates are affected by baseline host and viral factors and differ between treatment durations for certain subgroups [see Clinical Studies (14)].
Table 1 shows the recommended Ledifos treatment duration based on patient population.
For patients with HCV/HIV-1 co-infection, follow the dosage recommendations in Table 1 [see Clinical Studies (14)]. Refer to Drug Interactions (7) for dosage recommendations for concomitant HIV-1 antiviral drugs.
Get Best QuoteRequest A Callback